​
​

Carisma Therapeutics (CARM) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Carisma Therapeutics Revenue Highlights

Latest Revenue (Y)

$14.92M

Latest Revenue (Q)

$9.20M

Main Segment (Y)

License Revenue

Carisma Therapeutics Revenue by Period

Carisma Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$14.92M-62.70%
2022-12-31$40.00M50.69%
2021-12-31$26.54M136.24%
2020-12-31$11.24M100.00%
2019-12-31-100.00%
2018-12-31--100.00%
2017-12-31$425.00K-98.58%
2016-12-31$29.98M2928.38%
2015-12-31$990.00K-55.86%
2014-12-31$2.24M68.14%
2013-12-31$1.33M100.00%
2012-12-31-100.00%
2011-12-31--

Carisma Therapeutics generated $14.92M in revenue during NA 2023, up -62.70% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Carisma Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$9.20M170.74%
2024-03-31$3.40M-20.80%
2023-12-31$4.29M12.07%
2023-09-30$3.83M7.50%
2023-06-30$3.56M9.77%
2023-03-31$3.24M-13.08%
2022-12-31$3.73M44.72%
2022-09-30$2.58M-4.62%
2022-06-30$2.70M228.83%
2022-03-31$822.00K-95.89%
2021-12-31$20.00M100.00%
2021-09-30--100.00%
2021-06-30$2.23M-48.17%
2021-03-31$4.31M100.00%
2020-12-31--100.00%
2020-09-30$11.24M100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30--100.00%
2017-03-31$425.00K-48.48%
2016-12-31$825.00K-97.12%
2016-09-30$28.65M10242.96%
2016-06-30$277.00K20.96%
2016-03-31$229.00K-59.47%
2015-12-31$565.00K743.28%
2015-09-30$67.00K-41.23%
2015-06-30$114.00K-53.28%
2015-03-31$244.00K-34.93%
2014-12-31$375.00K-30.43%
2014-09-30$539.00K-29.17%
2014-06-30$761.00K33.98%
2014-03-31$568.00K11.37%
2013-12-31$510.00K-18.01%
2013-09-30$622.00K207.92%
2013-06-30$202.00K100.00%
2013-03-31-100.00%
2012-12-31--

Carisma Therapeutics generated $9.20M in revenue during Q2 2024, up 170.74% compared to the previous quarter, and up 283.60% compared to the same period a year ago.

Carisma Therapeutics Revenue Breakdown

Carisma Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 20
License Revenue$11.24M

Carisma Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 20: License Revenue (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 24
Milestones$2.00M

Carisma Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Milestones (100.00%).

Carisma Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
VECTVectivBio$27.34M$676.00K
CARMCarisma Therapeutics$14.92M$9.20M
PALIPalisade Bio$250.00K-
AVROAVROBIO--
CNSPCNS Pharmaceuticals--
CYTOAltamira Therapeutics-$52.73K
ZURAZura Bio--
ZVSAZyVersa Therapeutics--
IMMXImmix Biopharma--
HEPAHepion Pharmaceuticals--
ENVBEnveric Biosciences--
EFTReFFECTOR Therapeutics--

CARM Revenue FAQ

What is Carisma Therapeutics’s yearly revenue?

Carisma Therapeutics's yearly revenue for 2023 was $14.92M, representing a decrease of -62.70% compared to 2022. The company's yearly revenue for 2022 was $40M, representing an increase of 50.69% compared to 2021. CARM's yearly revenue for 2021 was $26.54M, representing an increase of 136.24% compared to 2020.

What is Carisma Therapeutics’s quarterly revenue?

Carisma Therapeutics's quarterly revenue for Q2 2024 was $9.2M, a 170.74% increase from the previous quarter (Q1 2024), and a 158.34% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $3.4M, a -20.80% decrease from the previous quarter (Q4 2023), and a 4.75% increase year-over-year (Q1 2023). CARM's quarterly revenue for Q4 2023 was $4.29M, a 12.07% increase from the previous quarter (Q3 2023), and a 14.96% increase year-over-year (Q4 2022).

What is Carisma Therapeutics’s revenue growth rate?

Carisma Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -43.80%, and for the last 5 years (2019-2023) was 0%.

What are Carisma Therapeutics’s revenue streams?

Carisma Therapeutics's revenue streams in c 20 are License Revenue

What is Carisma Therapeutics’s main source of revenue?

For the fiscal year ending Dec 20, the largest source of revenue of Carisma Therapeutics was License Revenue. This segment made a revenue of $11.24M, representing 100.00% of the company's total revenue.